Patent · US Active

Pathogenic biomarkers and serum extracellular vesicular biomarkers associated with vascular malformation of endothelial cells, and uses thereof

US11955241B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Wenbin Tan · Irvine, US
John Stuart Nelson · Laguna Niguel, US
Dongbao Chen · Irvine, US

Key dates

Filing date	Jun 3, 2019
Grant date	Apr 9, 2024
Priority date	—
Expiry date	Feb 8, 2043

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A90/10
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The disclosure provides for pathogenic biomarkers and serum extracellular vesicular biomarkers that are associated with vascular anomalies and malformation of endothelial cells, and uses thereof, including for diagnosis, prognosis and therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.